FDA inspection
Fibrocell Technologies, Inc.: FDA inspection ending Oct 12, 2012
FDA inspection 817419 · Voluntary Action Indicated (VAI) · Exton, PA
Key facts
| Inspection ID | 817419 |
|---|---|
| Firm | Fibrocell Technologies, Inc. |
| FEI number | 3005836954 |
| Address | 405 Eagleview Blvd |
| City | Exton |
| State | PA |
| ZIP | 19341 |
| Country | United States |
| Fiscal year | 2013 |
| Inspection end date | Oct 12, 2012 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data